ENDPOINTS

FDA puts two Chinese API makers on import alert after failed inspections

Chinese API manufacturers Wuhu Nuowei Chemistry and Chengdu Innovation Pharmaceutical have been placed on US import alert over issues with their quality control and testing methods. The import alerts mean that the FDA has the ...

Feb 11, 2025 - 19:27
 0
FDA puts two Chinese API makers on import alert after failed inspections
Chinese API manufacturers Wuhu Nuowei Chemistry and Chengdu Innovation Pharmaceutical have been placed on US import alert over issues with their quality control and testing methods. The import alerts mean that the FDA has the ...
Read More

Tags:

Previous Article

Novartis’s $925M Anthos Acquisition Brings Back Cardio Drug That Stops Blood Clots

Next Article

Fossil proteins may soon reveal how we're related to Australopithecus

Related Posts

Acelyrin and Alumis to merge in deal combining cash, assets

Acelyrin and Alumis to merge in deal combining cash, as...

Feb 9, 2025  0

#ASCOGU: Pfizer’s prostate cancer data leak shows promising results in early-stage study

#ASCOGU: Pfizer’s prostate cancer data leak shows promi...

Feb 11, 2025  0

Hims’ Super Bowl ad has drawn criticism from lawmakers — and now Novo Nordisk

Hims’ Super Bowl ad has drawn criticism from lawmakers ...

Feb 10, 2025  0